Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
about
sameAs
Inflammation, stress, and diabetesImmunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changesThe adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammationMammalian Krüppel-like factors in health and diseasesEndoplasmic reticulum stress and the inflammatory basis of metabolic diseaseMajor urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic miceAdipose is a conserved dosage-sensitive antiobesity geneFGF21, energy expenditure and weight loss - How much brown fat do you need?Metabolic functions of FABPs--mechanisms and therapeutic implicationsAdipokines as a novel link between obesity and atherosclerosisIdentification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding ProteinsX-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenalDevelopment of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetesObesity is associated with macrophage accumulation in adipose tissueThe Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent CellsThe role of fatty acid binding proteins in metabolic syndrome and atherosclerosisEndoplasmic reticulum stress and atherosclerosisTreatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal diseaseAdipose overexpression of heme oxygenase-1 does not protect against high fat diet-induced insulin resistance in miceThe fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activitiesEvaluation of circulating adipokines and abdominal obesity as predictors of significant myocardial ischemia using gated single-photon emission computed tomographyBinding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulationRole of the fatty acid binding protein mal1 in obesity and insulin resistanceThe role of adipocyte XBP1 in metabolic regulation during lactationMCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesityCre Recombinase Strains Used for the Study of Adipose Tissues and Adipocyte Progenitors.Adipocytokines in obesity and metabolic disease.Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis.Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma.Cell autonomous lipin 1 function is essential for development and maintenance of white and brown adipose tissueMechanisms by which diabetes increases cardiovascular disease.Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity.A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity.Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.Fatty acid binding protein 4 deficiency protects against oxygen-induced retinopathy in miceCombined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemiaFatty acid-binding proteins: role in metabolic diseases and potential as drug targets.Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
P2860
Q24523336-67CEEC0E-C1C6-4176-B6A0-32D6D09F19D4Q24532069-D84EE5BA-1CF8-42F3-B086-C39A65E287A7Q24550856-B7B26D77-76E7-4387-9830-9FD012EA3E69Q24612560-038156A7-1A46-4EC4-A230-0A4F34209BE1Q24633352-C1E7F106-F224-47EF-90B8-9AC336A28FD6Q24642546-32F98FCC-D1BD-4B68-94C2-39031BC04EFAQ24654087-BF9C6B2B-068B-4BF8-A677-D7D190D6A019Q26785678-D392978D-5325-4B35-B694-F1F064084531Q26799705-32C9F35B-CE85-42DF-88D3-6760765B4057Q26852200-BA243E49-1630-4B0D-9C7D-938DC96FEDD4Q27657435-4A60102B-683C-43EB-912B-A88AD569846CQ27662024-6BCA1823-D7DC-4F50-8EF5-58273E63C602Q27703246-02804A32-9FD0-4A1F-95B8-8FB3321813E5Q27860976-28E15976-3601-4F4B-ABB2-EB3E51BD3016Q28074203-187F4F69-EE61-43EC-8BEB-E61BA08175FEQ28271189-FC6A47D2-9537-4C2F-BFE7-6FFD7BB4FEC5Q28279152-EF4BBCC7-F6BC-4278-9A2A-B3C05A836D84Q28305340-01C9AB7F-41E8-4E51-AB59-1BF09EB99526Q28477907-E8509396-E754-4C8C-920E-B6FE04E9ECBAQ28485948-D84F73A6-31B8-4CBA-AB84-2D2F7E813746Q28513582-270D7101-8832-411D-B31A-27D51804E70FQ28538956-C42D1D26-65F8-4FEE-8041-6CF0ED90217DQ28539602-7A1D73C4-0239-49AE-A0BF-FD8EEF88F9A9Q28587094-F1AC2ADC-B226-449C-BFFC-27C53FD5FEAFQ28587096-C75A979D-5563-4696-8890-765CBDC20043Q29614283-1831A3B7-069A-4559-BEFC-2374E2EBAC7FQ30241907-088585A3-E6F7-46BD-8F27-E46CB2DC72C0Q30357655-5AA9F5AD-18E1-4ABB-AE80-B47A1957277AQ30412997-C439A864-2EA8-4724-AA11-C15FC678F41AQ30413957-CE587B24-8C8F-4BEC-A90E-14DF46964561Q30419099-83B3487A-4A03-48B9-88EA-7BB87863A4B2Q30441275-5A19EC76-2FB4-49D8-822E-8011036FA7E7Q30586189-75319725-63ED-4B42-8ECA-65ECBCE525B8Q33367128-F4358893-A212-44E7-9F80-4CA4FAEAB7F2Q33559605-AA0CDF31-618E-47E1-BEDD-6B0D5446C41BQ33572886-2DE91A7F-901E-4F20-A073-C65347420EE9Q33635135-214C281A-9C6A-482D-842A-08D44A2685CFQ33635141-32650D1A-7CD5-4541-BBF8-76833D8F50A2Q33649348-680A034A-DF77-4530-AE62-0B8143756A2BQ33669547-4DDFBFEE-030A-456E-8825-7836A67743C5
P2860
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@ast
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@en
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@nl
type
label
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@ast
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@en
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@nl
prefLabel
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@ast
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@en
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Lack of macrophage fatty-acid- ...... tein E against atherosclerosis
@en
P2093
G S Hotamisligil
L Makowski
M A Morgan
M F Linton
R A Parker
P2860
P2888
P304
P3181
P356
10.1038/89076
P407
P577
2001-06-01T00:00:00Z